PMC Articles for PubChem Compound (Select 6253) - PMC

Links from PubChem Compound

Items: 1 to 20 of 2905

<< First< Prev

Page of 146

Select item 113208941.

Clinical and safety outcomes of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) versus CEM (Carboplatin, Etoposide, Melphalan) in lymphoma patients as a conditioning regimen before autologous hematopoietic cell transplantation

Mohamed A. Eltelbanei, Noha A. El-Bassiouny, Mahmoud Salah Abdalla, Mohamed Khalaf, Rehab H. Werida

BMC Cancer. 2024; 24: 1002. Published online 2024 Aug 13. doi: 10.1186/s12885-024-12694-9

PMCID:: PMC11320894

Abstract Article PDF–2.3M

Select item 113098642.

Pseudocarcinomatous Hyperplasia of the Nose and Necrotic Tracheitis Associated with Acute Myeloid Leukemia

Shigehisa Kajikawa, Satsuki Murakami, Akiyoshi Takami, Akira Satou, Toyonori Tsuzuki, Tomoyuki Ogisu, Toshiyuki Yonezawa, Hiroyuki Tanaka, Akihito Kubo, Satoru Ito

Intern Med. 2024 Jul 15; 63(14): 2063–2067. Published online 2023 Nov 27. doi: 10.2169/internalmedicine.2625-23

PMCID:: PMC11309864

Abstract Article PDF–947K

Select item 112911923.

Efficacy and safety of stem cell mobilization with etoposide +cytarabine plus G-CSF in poor mobilizers with relapsed or refractory lymphoma

Zhijuan Zhu, Xiaofan Li, Xiaohong Yuan, Xianling Chen, Ting Lin, Xiangli Guo, Nainong Li

Front Immunol. 2024; 15: 1439253. Published online 2024 Jul 18. doi: 10.3389/fimmu.2024.1439253

PMCID:: PMC11291192

Abstract Article PDF–452K

Select item 112905164.

Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent

Nickolas Steinauer, Kristen McCullough, Aref Al-Kali, Hassan B. Alkhateeb, Kebede H. Begna, Abhishek A. Mangaonkar, Antoine N. Saliba, Mehrdad Torghabeh, Mark R Litzow, William J. Hogan, Mithun Shah, Mrinal M. Patnaik, Animesh Pardanani, Talha Badar, Hemant Murthy, James Foran, Cecilia Arana Yi, Ayalew Tefferi, Naseema Gangat

Haematologica. 2024 Aug 1; 109(8): 2706–2710. Published online 2024 Mar 28. doi: 10.3324/haematol.2024.284962

PMCID:: PMC11290516

Article PDF–1.9M

Select item 112834115.

Silencing of the DNA damage repair regulator PPP1R15A sensitizes acute myeloid leukemia cells to chemotherapy

Anthi Bouchla, Christina D. Sotiropoulou, Christopher Esteb, Theodoros Loupis, Sotirios G. Papageorgiou, Georgia G. Deliconstantinos, Maria Pagoni, Eleftheria Hatzimichael, Maria Dellatola, Smaragdi Kalomoiri, Elisavet Apostolidou, Christos K. Kontos, Thomas P. Thomopoulos, Theodoros Karantanos, Vasiliki Pappa

Ann Hematol. 2024; 103(8): 2853–2863. Published online 2024 Jun 6. doi: 10.1007/s00277-024-05785-x

PMCID:: PMC11283411

Abstract Article PDF–3.2M

Select item 112825876.

Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1

Li Liu, Qi Nie, Zugang Xiao, Xin Chen, Chunhui Yang, Xiaoyan Mao, Na Li, Yan Zhou, Qulian Guo, Xin Tian

BMC Pediatr. 2024; 24: 483. Published online 2024 Jul 27. doi: 10.1186/s12887-024-04954-1

PMCID:: PMC11282587

Abstract Article PDF–856K

Select item 112658987.

The outcome in pediatric acute myeloblastic leukemia; results of the first-line treatment and contribution of hematopoietic stem cell transplantation to survival of relapsed patients

Nazan SARPER, Intzi TACHSIN, Sema AYLAN GELEN, Emine ZENGİN

Turk J Med Sci. 2024; 54(2): 411–418. Published online 2023 Dec 11. doi: 10.55730/1300-0144.5806

PMCID:: PMC11265898

Abstract Article PDF–523K

Select item 112561748.

Clinical features, treatment, and outcome of juvenile dogs with meningoencephalitis of unknown etiology

Jack Galer, Alexander K. Forward, Jonathan Hughes, Abbe Harper Crawford, Sebastien Behr, Giunio Bruto Cherubini, Ine Cornelis, Emilie Royaux

J Vet Intern Med. 2024 Jul-Aug; 38(4): 2214–2220. Published online 2024 Jun 26. doi: 10.1111/jvim.17126

PMCID:: PMC11256174

Abstract Article PDF–505K

Select item 112494149.

"Off/On” Fluorescent Probe based on Aggregation-Induced Quenching of ZnO-Quantum dots for Determination of Ara-C: Pharmacokinetic Applications, Adsorption Kinetics & Green Profile Assessment

Marwa R. El-Zahry, Rania S. Ibrahim, Hanaa M. Abd El-Wadood, Horria A. Mohamed

J Fluoresc. 2024; 34(4): 1617–1630. Published online 2023 Aug 11. doi: 10.1007/s10895-023-03359-0

PMCID:: PMC11249414

Abstract Article PDF–2.8M

Select item 1124627710.

Novel Vpx virus-like particles to improve cytarabine treatment response against acute myeloid leukemia

Ramya Nair, Alejandro Salinas-Illarena, Monika Sponheimer, Inès Wullkopf, Yannick Schreiber, João Vasco Côrte-Real, Augusto del Pozo Ben, Helena Marterer, Dominique Thomas, Gerd Geisslinger, Jindrich Cinatl, Jr., Marion Subklewe, Hanna-Mari Baldauf

Clin Exp Med. 2024; 24(1): 155. Published online 2024 Jul 13. doi: 10.1007/s10238-024-01425-w

PMCID:: PMC11246277

Abstract Article PDF–3.5M

Select item 1122750811.

Hematopoietic stem and progenitor cell membrane-coated vesicles for bone marrow-targeted leukaemia drug delivery

Jinxin Li, Honghui Wu, Zebin Yu, Qiwei Wang, Xin Zeng, Wenchang Qian, Siqi Lu, Lingli Jiang, Jingyi Li, Meng Zhu, Yingli Han, Jianqing Gao, Pengxu Qian

Nat Commun. 2024; 15: 5689. Published online 2024 Jul 7. doi: 10.1038/s41467-024-50021-9

PMCID:: PMC11227508

Abstract Article PDF–4.0M

Select item 1122656012.

Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas

Sha Zhou, Jun Rao, Xiangyu Ma, Yunjing Zeng, Xixi Xiang, Jiali Li, Hongyun Liu, Shijia Lin, Song Dong, Fu Li, Xi Zhang, Li Gao

Int J Hematol. 2024; 120(1): 96–105. Published online 2024 Apr 8. doi: 10.1007/s12185-024-03755-7

PMCID:: PMC11226560

Abstract Article PDF–1.1M

Select item 1122566913.

Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101

Tracy T. Batchelor, Sharmila Giri, Amy S. Ruppert, Susan M. Geyer, Scott E. Smith, Nimish Mohile, Lode J. Swinnen, Jonathan W. Friedberg, Brad S. Kahl, Nancy L. Bartlett, Eric D. Hsi, Bruce D. Cheson, Nina Wagner-Johnston, Lakshmi Nayak, John P. Leonard, James L. Rubenstein

Blood Adv. 2024 Jun 25; 8(12): 3189–3199. Published online 2024 Apr 12. doi: 10.1182/bloodadvances.2023011657

PMCID:: PMC11225669

Abstract Article PDF–1.1M

Select item 1119104314.

Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC)

Ing Soo Tiong, Devendra K. Hiwase, Emad Abro, Ashish Bajel, Emma Palfreyman, Ashanka Beligaswatte, John Reynolds, Natasha Anstee, Tamia Nguyen, Sun Loo, Chong Chyn Chua, Michael Ashby, Kaitlyn M. Wiltshire, Shaun Fleming, Chun Y. Fong, Tse-Chieh Teh, Piers Blombery, Richard Dillon, Adam Ivey, Andrew H. Wei

J Clin Oncol. 2024 Jun 20; 42(18): 2161–2173. Published online 2024 Mar 1. doi: 10.1200/JCO.23.01599